MedPath

PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evaluation of FFR Measurements

Not Applicable
Completed
Conditions
Angina
Ischemia
Interventions
Device: St. Jude Medical Pressure Wire
Device: ACIST Navvus Microcatheter
Registration Number
NCT02648230
Lead Sponsor
Columbia University
Brief Summary

The model by which physicians measure the lack of blood flow in the vessels that supply blood to the heart muscle is called Fractional Flow Reserve (FFR). FFR is the measurement of the pressure across the vessels that supply blood to the heart. These are known as the coronary arteries. This study involves comparing two FFR wires, the St. Jude Medical Pressure Wire (PW) and the ACIST Navvus Microcatheter (MC) to check the accuracy of the devices. FFR allows real-time estimation of the effects of a narrowed vessel, whereas standard angiography can underestimate or overestimate narrowing, because it only visualizes contrast (the different areas of color) inside a vessel.

Detailed Description

Fractional flow reserve (FFR) measurement by pressure wire (PW) under hyperemic conditions has become the invasive gold standard for determining the physiologic extent of cardiac ischemia, and which has been validated in several clinical outcomes studies as a way of optimizing case selection for percutaneous coronary intervention (PCI). More recently a microcatheter (MC)-based sensor measurement of fractional flow reserve has been introduced. Small scale in-vivo comparisons have been performed suggesting the utility of this approach to measure FFR,but these data are limited and have not been independently validated. This non-randomized, prospective study is designed to evaluate the accuracy of MC-based FFR measurement to the PW standard in lesions subjected to FFR assessment in routine clinical practice.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  1. Age ≥ 18 years.
  2. Patient provides signed written informed consent before any study-specific procedure.
  3. Undergoing coronary angiography, for silent ischemia, stable angina, acute coronary syndrome, or other acceptable indication per the local standard of care.
  4. Angiographically significant (>50% visual estimation) stenosis present in at least one native coronary artery.
  5. Undergoing FFR assessment for standard clinical or diagnostic indications
Read More
Exclusion Criteria
  1. Aorto-ostial lesion location within 3 mm of the aorta junction (both right and left).
  2. Vessel(s) and lesion(s) not amenable for PCI, for example diffuse disease.
  3. Currently participating in another clinical study that interferes with study results.
  4. Pregnant or nursing subjects and those who plan pregnancy in the period up to 1 year following index procedure.
  5. Any other medical condition that in the opinion of the investigator will interfere with patient safety or study results.
  6. High degree A-V block, sinus node disease.
  7. Known hypersensitivity to adenosine
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pressure wire and MicrocatheterSt. Jude Medical Pressure WireAll subjects enrolled will have both an FFR done measured by a pressure wire (PW) and then again by a microcatheter (MC).
Pressure wire and MicrocatheterACIST Navvus MicrocatheterAll subjects enrolled will have both an FFR done measured by a pressure wire (PW) and then again by a microcatheter (MC).
Primary Outcome Measures
NameTimeMethod
Mean Fractional Flow Reserve (FFR)Through study completion (an average of an hour)

The mean FFR will be measured with the pressure catheter (PC) to be compared against the mean FFR measured with a standard Pressure Wire (PW) within the same subject across the same target lesion at the same time. Fractional flow reserve measurement involves determining the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Columbia University

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath